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ANNEMIEK NELIS 1 
 
Introduction 
On the basis of the title of this book, I expected something other then what I found 
inside. Rather than another, ethical analysis of the question of how we should collect, 
store and use genetic and other data in biobanks, the book reports an empirical study 
that includes the discussion of future scenarios with no fewer than 87 individuals 
worldwide. These individuals include academics (with a background in medicine, life-
sciences, social sciences, humanities and law), people from NGOs, members of 
national ethics committees, government representatives, independent consultants and 
employees of international organizations. Most intriguingly, the participants come 
from all continents, hence the subtitle ‘global perspectives’.  
 
Order of the book  
Before exploring further the results of this study, a few words about the order of the 
chapters and the way the book is constructed. The reason I want to pay attention to 
this aspect is because this is actually very well done in this particular volume (and 
such is not always the case if a collection of people publish an edited book as the 
result of their research project). The book starts with an overview of the ethical issues 
that can be found in the literature and that have shaped discussions on ethics and 
biobanks over the past few years. This chapter, written by Bartha M. Knoppers and 
Ma’n H. Abdul-Rahman, covers the major issues related to consent, confidentiality 
and commercialization. Here, these authors lay the groundwork for the rest of the 
book, introducing the notions of consent, anonymisation, ownership of data, right to 
withdrawal and so on. The next chapter, by Effy Vayena and her co-authors, touches 
upon more or less the same issues but explores how these are being dealt with and 
defined in international guidelines and recommendations, including those from WHO, 
HUGO, the OECD and others. The main focus of this chapter is both the (possibility 
for) emerging consensus and the unresolved controversies. As the reader has learned 
by this point, controversies prevail when talking about the ethics of biobanks.  
 
The second part, which really is the heart of the book, describes the results of the in-
depth interviews with people all over the globe. To structure these interviews, four 
scenarios were developed which were subsequently discussed with each of the 
interviewees. These scenarios are not so much alternative scenarios to describe 
different worlds, but rather portray different possible uses of biobanks:  
 
 Scenario A involves the setting up of a de novo international biobank with DNA 
extracted from biological specimens to enable research on colorectal polyps. In 
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this particular scenario, three countries collectively take the initiative for this 
biobank, which is overseen both by a steering committee and an independent 
Ethics Review Board (ERB). Part of this scenario concerns different options to 
anonyimise samples when they are being shipped to other countries; the 
possibility to withdraw samples; the use of samples for research other than 
colorectal polyps, and so on.  
 Scenario B describes a non-profit organization in country A that wants to set up a 
population biobank to enable research on the specific genetic characteristics of 
this population. In this case, samples cannot be transferred out of country A. 
Questions to the interviewees concern this territorial limitation (is it ethical, 
useful, possible) and who should profit from the use or exploitation of the data.  
 Scenario C describes a commercial company that wants to collect 2000 biological 
samples from an indigenous population in the country where the firm is based. 
Several options are presented as to what should be the relationship with and 
benefit for the members of the indigenous group.  
 Scenario D describes a local hospital that routinely asks clinical patients to give 
their consent to the storage of biological samples for research purposes. The ERB 
is being asked to choose between different forms of consent. Should patients 
consent to a general use of their specimen for medical research, for example, or 
should they be given the opportunity to consent to each research project 
separately?   
 
Discussion of Scenarios 
In subsequent chapters, different authors describe what different interviewees have to 
say about the ethical issues concerning biobanks as presented in the different 
scenarios. Chapter four, for example, written by Bernice Elger, uses scenarios A and 
D to discuss questions regarding the use of samples, in particular the type of consent 
that is necessary. The chapter discusses under what circumstances interviewees 
prefer: (a) informed consent for each new study; (b) presumed consent, meaning that 
consent is presupposed but information is given about each research project that is 
being done and participants are given the opportunity to opt out; (c) general consent 
for future studies; or (d) a mixture of the other three. Chapter five, by the same author, 
focuses on scenario B and discusses consent for the use of samples collected as part of 
medical care. Agomoni Ganguli-Mitra’s chapter uses scenario C to discuss the issue 
of ‘collective consent’. Under what conditions is collective consent relevant and 
ethically acceptable? Chapter eight deals with the issue of data withdrawal. Again, 
four options are discussed: (a) no right to withdrawal; (b) right to withdrawal 
restricted to irreversible anonymisation of samples and information; (c) right to 
withdrawal includes destruction of samples and information in the biobank; and (d) 
right to withdrawal includes destruction of samples and information, including 
samples and information given to researchers.  
 
Subsequent chapters follow suit and use different (parts of the) scenarios to discuss: 
anonymisation and coding; informing participants about research results; territorial 
restrictions using samples beyond national boundaries; public domain data sharing, 
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patents and fees; benefit-sharing and remuneration; and transfer of samples and 
sharing of results. 
 
Rich material  
The strength of the book is the rich and detailed exploration of the moral reasoning 
concerning a large number of controversial issues surrounding the development of 
new biobanks and the maintenance of existing biobanks. The book offers an excellent 
overview not only of the different issues involved but also of the controversies and 
questions that need to be considered. The interviews with professionals who are 
engaged with biobanks illustrate very vividly the many ways in which one could 
approach issues of consent, anonymisation, autonomy, privacy etc.  
 
The authors have managed to present their material in a very lively, compelling 
fashion, making use of a combination of ethical literature, international reports and 
guidelines and the statements and questions that have been raised during the in-depth 
interviews. Since the researchers use very realistic scenarios to explore the moral 
issues that are connected to biobanks, questions and controversies really come to life, 
clearly illustrated by well-chosen quotes. Interviews are analysed in a comparative 
manner, showing similarities as well as differences between experts representing 
different professions and organisations and between different geographical places.  
 
International comparison  
In a number of cases it is clear that interviewees have very different views concerning 
the use and storage of genetic and other data in biobanks. An interesting issue is the 
degree of trust that interviewees have in different arrangements. These differences are 
often linked to geographical places, to where interviewees are situated in the world. 
With respect to the issue of consent and the use of samples, for example, the authors 
report that their data indicates “a greater fear of abuse outside Europe and North 
America, in particular among members of indigenous groups” (p.83). What the 
researchers describe here is not only a general mistrust among interviewees outside 
Europe and North America, but also a different appreciation of existing institutions. 
Ethics committees, for example, have a different role and status in Europe and North-
America from that in other parts of the world: 
 
In Europe and North-America respondents seemed to identify the 
decision of an ethics committee with a form of collective permission, 
also referred to as custodianship of the samples, whereas 
respondents from developing countries and indigenous groups 
outside these regions made a clear difference between the decisions 
of ethics boards and the genuine instances of collective consent such 
as ancestor councils or other forms of tribal authorities. (p.118)  
 
Likewise, different regions in the world have a different attitude towards the question 
of what constitutes an individual. In some parts of the world this is related to families 
and tribes, which strongly shapes how people see bodily material and who is to decide 
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Differences between regions do not always play a role, however. With respect to the 
withdrawal of data from a biobank, for example, the researchers “did not find any 
significant differences in the attitudes of respondents from different regions” (p.161). 
On a number of occasions, differences seem to be determined rather by the 
professional background of respondents or the experiences they had with biobanks.  
 
Another finding is the difference between interviewees who do and do not have 
experience with storing samples. This difference is observed most strongly with 
respect to the issue of consent and the use of data for research purposes. Interviewees 
who have experiences with data storage themselves are more likely to opt for general 
informed consent, as opposed to new informed consent, than interviewees who have 
no personal experience with data storage. 
 
These findings can be explained in several ways: On the one hand 
respondents who used samples are in a better position to know about 
burdens they may have experienced themselves. On the other hand, 
as admitted by several respondents, researchers’ attitudes reflect 
their own interests to avoid inconvenience for research, and they 
may see the balance with patients right somewhat differently. (p.84) 
 
Methodology 
As mentioned earlier, from the title but also the list of authors – who come mainly 
from the field of ethics and law - I had not expected such a rich empirical study. To 
me, the book reads like a social scientist’s approach to ethics. However, I wonder 
whether the authors would describe their work in these terms. My impression is that 
the authors seem to consider the scenarios and interviews as more or less an 
instrument to explore ethical issues rather than a methodology/approach that deserves 
attention in its own right. The reader learns little about the actual method and 
approach that the authors have used to collect their (interview) data. I would have 
liked to read more about the construction of the scenarios, for example. The authors 
claim these were developed “following an extensive review of the existing literature 
and through discussions with experts in the field” (p.41). I am curious to know how 
this construction came about, what happened in the pilot runs and what were the 
experiences of the researchers in using the scenarios. Scenarios, in my experience, 
only work well if they are well defined, understandable and seem realistic to those 
who are presented with them. To develop a good scenario is anything but an easy 
task, but my impression is that the scenarios presented in this study were very well 
developed. That the reader cannot learn more about the development of these 




After finishing the book I was left with one important question: whether it is possible 
to ‘govern’ biobanks, as the title implies, and if so, how this governance should be 
organised. The authors claim they want to improve the ethical and regulatory 
frameworks of biobanks (p.7) but it is unclear what improvement means. The book 
balances between two opposed conclusions. On the one hand, the story hinges upon 
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the notion that governance of biobanks is something that can and should be achieved. 
On the other hand, the different chapters illustrate that biobanks are shaped by 
controversies and issues that are not easily managed or solved by regulation, 
harmonisation and standardisation.  
 
In parts of the book the reader is confronted with the difficulties of governance of 
biobanks. On a number of occasions the authors suggest that it is hard to draw 
conclusions, let alone make firm recommendations: “Our study does not provide an 
answer, but it demonstrates how important it is that these questions are raised and 
more openly discussed.” (p.163) In other chapters, we read that from the interviews 
some consensus or common ground has been observed. However, this does not 
necessarily lead to recommendations, and there is no overall conclusion or set of 
recommendations in the concluding chapter. 
 
Other parts of the book suggest that governing biobanks in an ethical way is both 
necessary and do-able. In several chapters, authors talk about the need for uniform 
international guidelines, harmonisation and standardisation and make 
recommendations about the conditions that allow for such uniformity: “The first step 
towards uniform international guidelines could be the implementation of trustworthy 
control mechanisms that fulfil local expectations of community representations.” 
(p.119) And, “If there is enough evidence that trustworthy ethics committees and 
feasible data security techniques exist to protect research participants even in 
developing countries and in indigenous populations, this could increase trust and 
make a moderate version of general consent acceptable.”(p.87).  
 
The interesting thing is that the empirical study indicates there are very few issues that 
seem to lend themselves to uniform guidelines, standardisation and regulation. Take 
the issue of commercialisation. Commercialisation is an issue that is often addressed 
in relation to biobanks and which most actors agree is a tricky issue. After all, when 
people donate bodily material and personal information freely, is it acceptable that 
biobanks somehow profit from this free donation later on?  At what cost and under 
what conditions could this be acceptable? The question is certainly relevant since 
many biobanks foresee that in the future commercialisation of data and information is 
the only way to organise a return on their investments. Although most individuals and 
official bodies agree that commercialisation should not lead to misuse and abuse of 
data and information that is donated voluntarily, even this topic does not lend itself 
for easy harmonisation and regulations.  
 
To some, scientific research is undermined if sustained by the profit 
motive. Scientific research is meant to advance knowledge in the 
public interest, and commercial inters undermines its basic nature. 
By contract, others noted that having commercial interests per se is 
ethically neutral and often provides the necessary incentives. (p.213) 
 
One may argue that the lack of recommendations and solutions is a weakness of the 
current study. Alternatively, however, one may also argue it is actually one of its 
strengths as it shows that ‘biobanks’ are perhaps not one single topic or theme. 
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Rather, biobanks bring together a variety of issues, technologies and common 
practices. These are both old and new technologies brought together in a different 
fashion and a different format. Time will tell how these new formations will help 
shape our social reality and how social realities will help shape what we call 
biobanks. Perhaps, if there is one conclusion that can be justified on the basis of this 
book, it is that we should stop using the combination of “biobanks” and “governance” 
as this suggests a more homogenous, controllable and foreseeable future than we 
really have.  
 
I strongly recommend this book to anyone who is interested in the topic of biobanks 
and who would like to understand more of the complicated discussions concerning 
them.  
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